CompletedPhase 2NCT01406769

Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

Studying Vulvar carcinoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Gynecologic Oncology Group
Principal Investigator: Jay W Carlson
Gynecologic Oncology Group
Intervention: Bioelectric Impedance Analysis(procedure)
Enrollment: 120 target
Eligibility: 18 years · FEMALE
Timeline: 2012 – 2020

Study locations (11)

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Mercy Hospital Springfield, Springfield, Missouri, United States
Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States
M D Anderson Cancer Center, Houston, Texas, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01406769 on ClinicalTrials.gov

Other trials for Vulvar carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Vulvar carcinoma →

← Back to all trials